Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3242511000168112 | Valsartan HCTZ 160/12.5 (Apotex) (hydrochlorothiazide 12.5 mg + valsartan 160 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3242521000168117 | Valsartan HCTZ 160/12.5 (Apotex) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Valsartan HCTZ 160/12.5 (Apotex) (hydrochlorothiazide 12.5 mg + valsartan 160 mg) tablet (trade product unit of use) | Is a | Valsartan HCTZ 160/12.5 (Apotex) | true | Inferred relationship | Some | ||
| Valsartan HCTZ 160/12.5 (Apotex) (hydrochlorothiazide 12.5 mg + valsartan 160 mg) tablet (trade product unit of use) | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Valsartan HCTZ 160/12.5 (Apotex) (hydrochlorothiazide 12.5 mg + valsartan 160 mg) tablet (trade product unit of use) | Is a | valsartan 160 mg + hydrochlorothiazide 12.5 mg tablet | true | Inferred relationship | Some | ||
| Valsartan HCTZ 160/12.5 (Apotex) (hydrochlorothiazide 12.5 mg + valsartan 160 mg) tablet (trade product unit of use) | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Valsartan HCTZ 160/12.5 (Apotex) (hydrochlorothiazide 12.5 mg + valsartan 160 mg) tablet (trade product unit of use) | has unit of use | tablet | true | Inferred relationship | Some | 667516895 | |
| Valsartan HCTZ 160/12.5 (Apotex) (hydrochlorothiazide 12.5 mg + valsartan 160 mg) tablet (trade product unit of use) | has Australian BoSS | hydrochlorothiazide | true | Inferred relationship | Some | 667516894 | |
| Valsartan HCTZ 160/12.5 (Apotex) (hydrochlorothiazide 12.5 mg + valsartan 160 mg) tablet (trade product unit of use) | has intended active ingredient | hydrochlorothiazide | true | Inferred relationship | Some | 667516894 | |
| Valsartan HCTZ 160/12.5 (Apotex) (hydrochlorothiazide 12.5 mg + valsartan 160 mg) tablet (trade product unit of use) | has intended active ingredient | valsartan | true | Inferred relationship | Some | 362894494 | |
| Valsartan HCTZ 160/12.5 (Apotex) (hydrochlorothiazide 12.5 mg + valsartan 160 mg) tablet (trade product unit of use) | has Australian BoSS | valsartan | true | Inferred relationship | Some | 362894494 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Valsartan HCTZ 160/12.5 (Apotex) tablet, 28 | has TPUU | True | Valsartan HCTZ 160/12.5 (Apotex) (hydrochlorothiazide 12.5 mg + valsartan 160 mg) tablet (trade product unit of use) | Inferred relationship | Some | 1 |
| Valsartan HCTZ 160/12.5 (Apotex) tablet, 28, blister pack | has TPUU | True | Valsartan HCTZ 160/12.5 (Apotex) (hydrochlorothiazide 12.5 mg + valsartan 160 mg) tablet (trade product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR